Labcorp’s latest acquisition brings the oncology testing business of BioReference Health. Opko Health, BioReference’s parent, has been cutting costs to return to profitability.
The post Labcorp Is Buying BioReference Health’s Cancer Testing Business for $192M appeared first on MedCity News.
Bengali (Bangladesh) · 
English (United States) ·